Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shlipak

Showing results (61-70 of 736) with videos related to

Pageof 74
Sort By:
Data in Brief|August 24, 2017
Associations of TNFR1 with kidney function outcomes by age, gender, and baseline kidney function status: Data from the Heart and Soul StudyMeyeon Park, Daniela Maristany, Debbie Huang, et al.
American Journal of Hypertension|September 1, 2006
Kidney function and systolic blood pressure new insights from cystatin C: data from the Heart and Soul StudyCarmen A Peralta, Mary A Whooley, Joachim H Ix, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 6, 2007
Association of cystatin C with poor exercise capacity and heart rate recovery: data from the heart and soul studyDavid McManus, Michael Shlipak, Joachim H Ix, et al.
Journal of the American Society of Nephrology : JASN|October 6, 2018
Association of Soluble TNFR-1 Concentrations with Long-Term Decline in Kidney Function: The Multi-Ethnic Study of AtherosclerosisPavan K Bhatraju, Leila R Zelnick, Michael Shlipak, et al.
Clinical Chemistry|March 3, 2011
Calibration of the Siemens cystatin C immunoassay has changed over timeAnders Larsson, Lars-Olof Hansson, Mats Flodin, et al.
Journal of the American Geriatrics Society|December 31, 2025
Reply to: Intensive Blood Pressure Targets in Geriatrics: Individualized Decision-Making and Unresolved RisksMitra S Jamshidian, Joachim H Ix, Michael G Shlipak, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 29, 2009
Fibroblast growth factor-23 and early decrements in kidney function: the Heart and Soul StudyJoachim H Ix, Michael G Shlipak, Christina L Wassel, et al.
Journal of the American Society of Nephrology : JASN|March 23, 2013
Fractional excretion of phosphorus modifies the association between fibroblast growth factor-23 and outcomesJulie R Dominguez, Michael G Shlipak, Mary A Whooley, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 31, 2011
Risk factors for ESRD in HIV-infected individuals: traditional and HIV-related factorsVasantha Jotwani, Yongmei Li, Carl Grunfeld, et al.
Kidney Medicine|May 1, 2026
Tubular Stress Markers and Future Risk of Sepsis-Associated Acute Kidney InjuryAngela K Wong, Michael G Shlipak, Orlando M Gutierrez, et al.
Pageof 74

Showing results (61-70 of 736) with videos related to

Sort By:
Pageof 74
Data in Brief|August 24, 2017
Associations of TNFR1 with kidney function outcomes by age, gender, and baseline kidney function status: Data from the Heart and Soul StudyMeyeon Park, Daniela Maristany, Debbie Huang, et al.
American Journal of Hypertension|September 1, 2006
Kidney function and systolic blood pressure new insights from cystatin C: data from the Heart and Soul StudyCarmen A Peralta, Mary A Whooley, Joachim H Ix, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 6, 2007
Association of cystatin C with poor exercise capacity and heart rate recovery: data from the heart and soul studyDavid McManus, Michael Shlipak, Joachim H Ix, et al.
Journal of the American Society of Nephrology : JASN|October 6, 2018
Association of Soluble TNFR-1 Concentrations with Long-Term Decline in Kidney Function: The Multi-Ethnic Study of AtherosclerosisPavan K Bhatraju, Leila R Zelnick, Michael Shlipak, et al.
Clinical Chemistry|March 3, 2011
Calibration of the Siemens cystatin C immunoassay has changed over timeAnders Larsson, Lars-Olof Hansson, Mats Flodin, et al.
Journal of the American Geriatrics Society|December 31, 2025
Reply to: Intensive Blood Pressure Targets in Geriatrics: Individualized Decision-Making and Unresolved RisksMitra S Jamshidian, Joachim H Ix, Michael G Shlipak, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 29, 2009
Fibroblast growth factor-23 and early decrements in kidney function: the Heart and Soul StudyJoachim H Ix, Michael G Shlipak, Christina L Wassel, et al.
Journal of the American Society of Nephrology : JASN|March 23, 2013
Fractional excretion of phosphorus modifies the association between fibroblast growth factor-23 and outcomesJulie R Dominguez, Michael G Shlipak, Mary A Whooley, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 31, 2011
Risk factors for ESRD in HIV-infected individuals: traditional and HIV-related factorsVasantha Jotwani, Yongmei Li, Carl Grunfeld, et al.
Kidney Medicine|May 1, 2026
Tubular Stress Markers and Future Risk of Sepsis-Associated Acute Kidney InjuryAngela K Wong, Michael G Shlipak, Orlando M Gutierrez, et al.
Pageof 74